Fighting for PrEP medication coverage under the ACA with Stephen Parodi, MD

How a physician's quest to ensure patient access to PrEP—a key medication in preventing HIV infection in high-risk patients—has gained national traction with help from the AMA Integrated Physician Practice Section (IPPS). Stephen Parodi, MD, executive vice president of external affairs, communications and brand at The Permanente Federation, and associate executive director for The Permanente Medical Group in Oakland, Calif., discusses how the AMA House of Delegates (AMA-HOD) and AMA-IPPS supported action regarding insurance coverage for Pre-exposure Prophylaxis medication, or PrEP, under the Affordable Care Act (#ACA). American Medical Association CXO Todd Unger hosts. For more on the AMA's amicus brief filing and involvement in Braidwood Management v. Becerra case, visit: https://www.ama-assn.org/delivering-care/patient-support-advocacy/leave-aca-s-zero-cost-preventive-care-intact-ama-tells